Read Time: 2 minutes
The WHO has just given a category of excellence to the Cuban vaccine against the Sovereign 2 coronavirus, “which, (is even suitable for pediatric use, something that no current vaccine had achieved)” The Sovereign 2 was developed in Cuba, it is the Latin American vaccine against coronavirus and after phase III tests it would be ready in May. “The Cuban Soberana 02 hit the ground running in the continent. It is on the select list of vaccines of the World Health Organization (WHO), it is the first made in Latin America that passed phase 2 of clinical trials and has an advantage that makes it distinctive:
- can be applied in pediatric population. “The vaccine entered the successive stages of testing on October 19 of last year and at the beginning of March, the pharmaceutical company BioCubaFarma confirmed that the Regulatory Authority of Medicines, Equipment and Medical Devices of Cuba (Cecmed) gave the green light to the final stage of investigation “. At least” 90 thousand Cubans from ten communes were injected “for this test and Cecmed itself guaranteed the” exhaustive evaluation of the previous trials “and described it as a” very safe “vaccine. It is a” conjugated drug in which the virus antigen and tetanus toxoid are combined, thus it is expected that immunity reaches the mucosa of the respiratory tract in order to prevent the entry of the virus “. “In other words, it would prevent contagion *, something that not all the vaccines applied so far guarantee; what is confirmed, they reduce symptoms and reduce the risk of death.”